Pinnacle West Asset Management Inc. Raises Stock Holdings in The Clorox Company (NYSE:CLX)

Pinnacle West Asset Management Inc. boosted its holdings in shares of The Clorox Company (NYSE:CLX) by 12.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,705 shares of the company’s stock after purchasing an additional 190 shares during the quarter. Pinnacle West Asset Management Inc.’s holdings in Clorox were worth $277,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. State Street Corp boosted its position in Clorox by 3.1% during the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after purchasing an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC lifted its position in shares of Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after acquiring an additional 4,490,421 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Clorox by 1.1% in the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock valued at $491,713,000 after acquiring an additional 33,970 shares in the last quarter. Stifel Financial Corp lifted its position in shares of Clorox by 1.7% in the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock valued at $380,370,000 after acquiring an additional 37,967 shares in the last quarter. Finally, Van ECK Associates Corp lifted its position in shares of Clorox by 2.2% in the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock valued at $237,372,000 after acquiring an additional 31,510 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

CLX stock opened at $157.00 on Wednesday. The business has a fifty day moving average of $157.40 and a two-hundred day moving average of $160.13. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The stock has a market cap of $19.34 billion, a price-to-earnings ratio of 42.90, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.

Clorox (NYSE:CLX) last posted its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the business earned $2.16 earnings per share. As a group, research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.11%. Clorox’s dividend payout ratio (DPR) is 133.33%.

Wall Street Analyst Weigh In

CLX has been the topic of several research reports. JPMorgan Chase & Co. raised their target price on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research report on Tuesday, February 4th. Barclays raised their target price on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday, February 5th. Wells Fargo & Company raised their target price on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 4th. Evercore ISI raised their target price on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Finally, TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and raised their target price for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $158.21.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.